New: Introducing the Finviz Crypto Map

Learn More
Last Close
Aug 18 11:27AM ET
10.52
Dollar change
-3.48
Percentage change
-24.86
%
Index- P/E- EPS (ttm)-485.03 Insider Own8.37% Shs Outstand0.66M Perf Week39.89%
Market Cap28.33M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float0.55M Perf Month-17.30%
Enterprise Value24.21M PEG- EPS next Q- Inst Own1.31% Short Float- Perf Quarter-58.12%
Income-4.50M P/S4.39 EPS this Y- Inst Trans- Short Ratio- Perf Half Y-95.48%
Sales6.45M P/B1.18 EPS next Y- ROA-58.34% Short Interest- Perf YTD-97.64%
Book/sh8.89 P/C6.71 EPS next 5Y- ROE-101.49% 52W High1212.99 -99.13% Perf Year-98.98%
Cash/sh1.57 P/FCF- EPS past 3/5Y90.62% 80.05% ROIC-77.17% 52W Low7.48 40.64% Perf 3Y-99.99%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-16.19% 19.53% Gross Margin62.59% Volatility43.18% 17.56% Perf 5Y-100.00%
Dividend TTM- EV/Sales3.75 EPS Y/Y TTM92.38% Oper. Margin-97.54% ATR (14)2.33 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.97 Sales Y/Y TTM-19.81% Profit Margin-69.71% RSI (14)48.03 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio2.77 EPS Q/Q97.55% SMA20-1.72% Beta1.05 Target Price5800.00
Payout- Debt/Eq0.02 Sales Q/Q-36.79% SMA50-0.84% Rel Volume0.50 Prev Close14.00
Employees18 LT Debt/Eq0.00 EarningsMay 21 BMO SMA200-94.65% Avg Volume872.97K Price10.52
IPOOct 06, 2016 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume144,848 Change-24.86%
Vyome Holdings, Inc. engages in the development of immuno-inflammatory assets. It focuses on therapeutic solutions that target formulations for site-targeted applications. The company was founded on January 2, 2008 and is headquartered in San Clemente, CA.